Post-Marketing Surveillance of Fluvoxamine Maleate Used Long-Term in Patients with Social Anxiety Disorder in Japan.

ABSTRACT:

Background

No data on the long-term 'real-world' use of fluvoxamine for the treatment of social anxiety disorder (SAD) in Japanese patients are currently available.

Objective

To evaluate the long-term safety and efficacy of fluvoxamine for SAD in the clinical setting.

Methods

Japanese patients with SAD who initiated treatment with fluvoxamine were enrolled in this 53-week post-marketing survey from 407 institutions nationwide. Data including rates of adverse drug reactions (ADRs) and efficacy were collected. Overall improvement was assessed using the Clinical Global Impression for Improvement. SAD symptoms and treatment responses were assessed with the Japanese version of the Liebowitz Social Anxiety Scale.

Results

From the 1,974 patients surveyed, 1,790 and 1,

SUBMITTER: Asakura S 

PROVIDER: S-EPMC4883186 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature